Icahn Is No Saint, but Illumina Can Still Use a Flawed Savio

Despite a short seller’s accusations that his company has inflated its asset prices, Carl Icahn’s effort to shake up Illumina is still in the interest of shareholders

Related Keywords

Adam Jeffery , Carl Icahn , Photo Bank Getty Images , Biotechnology Services , Machinery , Healthcare Life Sciences , Genomics , Industrial Goods , Management , Shareholder Activism , Corporate Industrial News , Corporate Governance , Environmental Social Governance , Content Types , Factiva Filters , C Ampe Industry News Filter , Synd , Wsj Pro Com , Illumina , Ilmn , Corporate , Industrial News , Environmental , Social , Governance , Healthcare , Life Sciences ,